Ulrich M. Zanger

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology — Germany

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

84h-index26.5kcitations245works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(131), Drug Transport and Resistance Mechanisms(93), Pharmacological Effects and Toxicity Studies(23), Hormonal Regulation and Hypertension(20), HIV/AIDS drug development and treatment(19)

Publications243 total

Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liver
Pharmacological Research·2025· 3 citedOpen Access
In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants
British Journal of Pharmacology·2024· 1 citedOpen Access
Unnatural Endotype B PPAPs as Novel Compounds with Activity against <i>Mycobacterium tuberculosis</i>
Journal of Medicinal Chemistry·2023· 5 cited
Unnatural endo type-B PPAPs as novel compounds with activity against Mycobacterium tuberculosis.
2023· 1 citedOpen Access
Unnatural endo type-B PPAPs as novel compounds with activity against Mycobacterium tuberculosis.
2023· 1 citedOpen Access
Unnatural endo type-B PPAPs as novel compounds with activity against Mycobacterium tuberculosis.
2023Open Access
Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid Homeostasis
Frontiers in Pharmacology·2021· 14 citedOpen Access
Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Breast Cancer Research·2021Open Access
Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells
Scientific Reports·2021· 15 citedOpen Access
P450 Monooxygenase System
2021· 1 cited
Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver Cells
International Journal of Molecular Sciences·2020· 63 citedOpen Access
Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
UNC Libraries·2020Open Access
Tri‐Allelic Haplotypes Determine and Differentiate Functionally Normal Allele <i>CYP2D6*2</i> and Impaired Allele <i>CYP2D6*41</i>
Clinical Pharmacology & Therapeutics·2020· 10 citedOpen Access
FUSAFE abstract on MIR27A/DPYD genotyping
UEA Digital Repository (University of East Anglia)·2020
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Breast Cancer Research·2020· 53 citedOpen Access
Abstract P2-04-02: Progesterone receptor membrane component 1 - A novel key regulator in lipid homeostasis drives oncogenic signaling resulting in breast cancer progression
Cancer Research·2020
TGF-β2 silencing to target biliary-derived liver diseases
Gut·2020· 43 citedOpen Access
P450 Monooxygenase System
2020
Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression
Human Genetics·2019· 18 cited
MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation
Biochemical Pharmacology·2019· 46 cited
page 1 of 13Next →

Frequent Co-authors

Matthias Schwab(27), Michel Eichelbaum(21), Kathrin Klein(17), Elke Schaeffeler(12), Urs Meyer(7), Oliver Burk(7), Jürgen Brockmöller(7), Leszek Wojnowski(7), Elisabeth Hustert(5), Julia Blievernicht(5), Tanja Saußele(5), Renzo Wolbold(4), P. Neuhaus(4), Joachim E. Fischer(4), Andreas K. Nüssler(4), Stefan Winter(4), Sebastian Raimundo(3), Ute Hofmann(3), Anne T. Nies(3), Ina Koch(3)